Personalized Treatment in Myelofibrosis: Applying the Data to Address Barriers and Improve Care

Expert faculty discuss the pharmacist’s role in the treatment of myelofibrosis, toxicity management, and monitoring with an on-demand webcast of a live symposium, downloadable slides, and commentary.

Share

Program Content

Activities

Personalized Treatment in MF
Personalized Treatment in Myelofibrosis: Applying the Data to Address Barriers and Improve Care
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 28, 2023

Activities

Personalized Treatment in MF: On-Demand Webcast
Personalized Treatment in Myelofibrosis: Applying the Data to Address Barriers and Improve Care
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 07, 2023

Expires: June 06, 2024

Activities

First-line MF Treatment
Expert Insights on Personalizing First-line Medication Therapy for Myelofibrosis
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 23, 2023

Faculty

cover img faculity

Emily Hollinghurst, PharmD, BCOP, CSP, APh

Assistant Professor
Department of Pharmacy Practice
Loma Linda University, School of Pharmacy
Clinical Pharmacy Specialist
Specialty Pharmacy Services
Loma Linda University Medical Center
Loma Linda, California

cover img faculity

Victoria Nachar, PharmD, BCOP

Clinical Pharmacist Specialist, Hematology
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan

Provided by

ProCE Banner

Provided by ProCE, LLC, in partnership with Clinical Care Options, LLC.

Supporters

This educational activity is supported by an educational grant from GSK.

GSK

Partners

Clinical Care Options, LLC

ProCE Banner